Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report.
Afr Health Sci
; 19(2): 2290-2293, 2019 Jun.
Article
en En
| MEDLINE
| ID: mdl-31656515
ABSTRACT
Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Espacio Retroperitoneal
/
Inhibidores del Factor Xa
/
Rivaroxabán
/
Hematoma
/
Hemorragia
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Afr Health Sci
Asunto de la revista:
MEDICINA
/
SERVICOS DE SAUDE
Año:
2019
Tipo del documento:
Article
País de afiliación:
Turquía